As a partner with Novartis on JAK inhibitor Jakafi, Incyte has pinned its future fortunes on the success […]

For about two months, Alexion has been exploring whether its Soliris—used to treat several rare diseases—might hold promise in treating […]

As an ex-army surgeon and a military historian, we have previously felt uneasy about healthcare workers being described […]

The data is being used by researchers to evaluate the effectiveness of a number of potential treatments

Study aiming to enrol 3,000 patients via more than 100 GP surgeries

Frontline workers now eligible for testing will include the police, the fire service, frontline benefits workers and those […]

The agency concluded that the risks of the medicine outweigh its benefits

Incyte’s Pemazyre can now be used to treat the bile duct cancer. The firm has also launched a […]

AstraZeneca investors are once again taking issues with CEO Pascal Soriot’s compensation package, just like they have repeatedly […]

Two remdesivir trials in China have been suspended due to low enrollment. The FDA has cleared a trio […]